Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Bates, David O  [Clear All Filters]
2023
Lobo MElisa Da V, Bates DO, Arkill KP, Hulse RPhilip. Measurement of solute permeability in the mouse spinal cord. J Neurosci Methods. 2023:109880.
Myint KZwar, Sueca-Comes M, Collier P, Balasubramanian B, Venkatraman S, Gordan J, Zaitoun AM, Mukherjee A, Arora A, Larbcharoensub N, et al. Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma. Front Oncol. 2023;13:1184900.
2022
Supradit K, Boonsri B, Duangdara J, Thitiphatphuvanon T, Suriyonplengsaeng C, Kangsamaksin T, Janvilisri T, Tohtong R, Yacqub-Usman K, Grabowska AM, et al. Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis. Toxicol In Vitro. 2022:105385.
Sueca-Comes M, Rusu ECristina, Grabowska AM, Bates DO. Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome. Pharmacol Rev. 2022;74(4):1136-1145.
Malhi NK, Allen CL, Stewart E, Horton KL, Riu F, Batson J, Amoaku W, Morris JC, Arkill KP, Bates DO. Serine/arginine rich protein kinase-1 (SRPK1) inhibition for the treatment of diabetic retinopathy. Am J Physiol Heart Circ Physiol. 2022.
2019
Machado MJC, Boardman R, Riu F, Emanueli C, Benest AV, Bates DO. Enhanced Notch signaling modulates unproductive revascularization in response to Nitric Oxide-Angiopoietin signaling in a mouse model of peripheral ischemia. Microcirculation. 2019:e12549.
2015
Bunni J, Shelley-Fraser G, Stevenson K, Oltean S, Salmon A, Harper SJ, Carter JG, Bates DO. Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratios. Am J Cancer Res. 2015;5(6):2083-9.
Wu W-K, Georgiadis A, Copland DA, Liyanage S, Luhmann UFO, Robbie SJ, Liu J, Wu J, Bainbridge JW, Bates DO, et al. IL-4 Regulates Specific Arg-1(+) Macrophage sFlt-1-Mediated Inhibition of Angiogenesis. Am J Pathol. 2015.
Vieira GCunha, Chockalingam S, Melegh Z, Greenhough A, Malik S, Szemes M, Park JHyun, Kaidi A, Zhou L, Catchpoole D, et al. LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma. Oncotarget. 2015.